(Circulation. 1996;93:1647-1650.)
© 1996 American Heart Association, Inc.
Articles |
Endothelium-Dependent Coronary Vasomotion Relates to the Susceptibility of LDL to Oxidation in Humans
From the Cardiovascular Division (T.J.A., I.T.M., A.C.Y., F.C., A.P.S., P.G.), Brigham and Women's Hospital, Harvard Medical School, Boston; and the Department of Medicine and Biochemistry (B.F.), Boston University School of Medicine, Boston, Mass.
Background Oxidatively modified LDL has been shown to markedly impair endothelium-dependent dilation in experimental studies. The aim of the present study was to determine the relation between the coronary vasomotor response to the endothelium-dependent agonist acetylcholine and the in vitro susceptibility of LDL to oxidation in patients.
Methods and Results Endothelium-dependent coronary vasomotion in response to acetylcholine (10-8 to 10-6 mol/L) was assessed in 23 patients with hypercholesterolemia (mean age, 56±9 years) after 1 year of therapy with either an American Heart Association Step 1 diet (seven patients), lovastatin and cholestyramine (seven patients), or lovastatin and probucol (nine patients). The susceptibility of LDL to oxidation was determined by measuring the lag phase of conjugated diene formation induced by Cu2+. Patients treated with lovastatin and probucol had prolongation of the lag phase (263±64 minutes) compared with diet- (91±22 minutes) or lovastatin and cholestyramine– (118±57 minutes) treated patients (P<.0001). By univariate analysis, the coronary vasomotor response to acetylcholine was significantly related to the lag phase of conjugated diene formation (P=.002), cholesterol-lowering therapy (P=.002), and serum cholesterol (P=.02). By multivariate analysis, the lag phase remained a significant predictor of the acetylcholine vasomotor response, independent of the effect of cholesterol-lowering treatment.
Conclusions In patients treated with lipid-lowering agents, the vasodilator response to acetylcholine is related to the susceptibility of LDL to oxidation. These findings suggest that oxidative stress is an important determinant of the coronary endothelial dysfunction observed in patients with atherosclerosis and hypercholesterolemia.
Key Words: endothelium • endothelium-derived factors • antioxidants • acetylcholine • cholesterol
This article has been cited by other articles:
 |
|
 |
|
  B. Pemp, G. Weigert, K. Karl, U. Petzl, M. Wolzt, L. Schmetterer, and G. Garhofer Correlation of Flicker-Induced and Flow-Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers Diabetes Care, August 1, 2009; 32(8): 1536 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Atkin, A. Gasper, R. Ullegaddi, and H. J. Powers Oxidative Susceptibility of Unfractionated Serum or Plasma: Response to Antioxidants in Vitro and to Antioxidant Supplementation Clin. Chem., November 1, 2005; 51(11): 2138 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Stone, D. M. Lloyd-Jones, S. Kinlay, B. Frei, W. Carlson, J. Rubenstein, T. C. Andrews, M. Johnstone, G. Sopko, H. Cole, et al. Effect of Intensive Lipid Lowering, With or Without Antioxidant Vitamins, Compared With Moderate Lipid Lowering on Myocardial Ischemia in Patients With Stable Coronary Artery Disease: The Vascular Basis for the Treatment of Myocardial Ischemia Study Circulation, April 12, 2005; 111(14): 1747 - 1755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumoto, H. Takashima, N. Ohira, Y. Tarutani, Y. Yasuda, T. Yamane, S. Matsuo, and M. Horie Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin J. Am. Coll. Cardiol., July 21, 2004; 44(2): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Hurst and R. W. Lee Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management Ann Intern Med, November 18, 2003; 139(10): 824 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsimikas and J. L. Witztum Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st century J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2122 - 2124. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Fang, S. Kinlay, D. Behrendt, H. Hikita, J. L. Witztum, A. P. Selwyn, and P. Ganz Circulating Autoantibodies to Oxidized LDL Correlate With Impaired Coronary Endothelial Function After Cardiac Transplantation Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2044 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Yen, G. Pilkington, R. C. Starling, N. B. Ratliff, P. M. McCarthy, J. B. Young, G. M. Chisolm, and M. S. Penn Increased Tissue Factor Expression Predicts Development of Cardiac Allograft Vasculopathy Circulation, September 10, 2002; 106(11): 1379 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Delbosc, J.-P. Cristol, B. Descomps, A. Mimran, and B. Jover Simvastatin Prevents Angiotensin II-Induced Cardiac Alteration and Oxidative Stress Hypertension, August 1, 2002; 40(2): 142 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wakatsuki, Y. Okatani, N. Ikenoue, and T. Fukaya Effect of Medroxyprogesterone Acetate on Endothelium-Dependent Vasodilation in Postmenopausal Women Receiving Estrogen Circulation, October 9, 2001; 104(15): 1773 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. A. Williams, W. H. F. Sutherland, M. P. McCormick, S. A. de Jong, J. R. McDonald, and R. J. Walker Vitamin C improves endothelial dysfunction in renal allograft recipients Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1251 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Penny, O. Ben-Yehuda, K. Kuroe, J. Long, A. Bond, V. Bhargava, J. F. Peterson, M. McDaniel, J. Juliano, J. L. Witztum, et al. Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein J. Am. Coll. Cardiol., March 1, 2001; 37(3): 766 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Wilson, R. D. Simari, P. J. M. Best, T. E. Peterson, L. O. Lerman, M. Aviram, K. A. Nath, D. R. Holmes Jr, and A. Lerman Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Nickenig, A. Stablein, S. Wassmann, C. Wyen, C. Muller, and M. Bohm Acute effects of ACE inhibition on coronary endothelial dysfunction Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 361 - 364. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Tomasian, J. F. Keaney Jr., and J. A. Vita Antioxidants and the bioactivity of endothelium-derived nitric oxide Cardiovasc Res, August 18, 2000; 47(3): 426 - 435. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann, T. Gnecchi-Ruscone, K. P. Schafers, T. F. Luscher, and P. G. Camici Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia J. Am. Coll. Cardiol., July 1, 2000; 36(1): 103 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Williams, R. Scalia, K. D. Mazany, W. V. Rodrigueza, and A. M. Lefer Rapid Restoration of Normal Endothelial Functions in Genetically Hyperlipidemic Mice by a Synthetic Mediator of Reverse Lipid Transport Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. P. Skyrme-Jones, R. C. O'Brien, M. Luo, and I. T. Meredith Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes J. Am. Coll. Cardiol., February 1, 2000; 35(2): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A P Mansur, C V Serrano Jr, J C Nicolau, L A M César, and J A F Ramires Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms Heart, December 1, 1999; 82(6): 689 - 693. [Abstract] [Full Text]
|
|
|
|
|
|
K. K. Koh, A. Blum, L. Hathaway, R. Mincemoyer, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III Vascular Effects of Estrogen and Vitamin E Therapies in Postmenopausal Women Circulation, November 2, 1999; 100(18): 1851 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. B. Tan, V. H. G. Ai, W. S. Chow, M. T. Chau, L. Leong, and K. S. L. Lam Influence of Low Density Lipoprotein (LDL) Subfraction Profile and LDL Oxidation on Endothelium-Dependent and Independent Vasodilation in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3212 - 3216. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Lekakis, C. Papamichael, K. Stamatelopoulos, A. Cimponeriu, A. Voutsas, K. Vemmos, M. Mavrikakis, and S. Stamatelopoulos Hemochromatosis associated with endothelial dysfunction: evidence for the role of iron stores in early atherogenesis Vascular Medicine, August 1, 1999; 4(3): 147 - 148. [Abstract] [PDF]
|
|
|
|
|
|
A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dupuis, J.-C. Tardif, P. Cernacek, and P. Theroux Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes : The RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) Trial Circulation, June 29, 1999; 99(25): 3227 - 3233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Caligiuri, B. Levy, J. Pernow, P. Thoren, and G. K. Hansson Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice PNAS, June 8, 1999; 96(12): 6920 - 6924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Schnell, A. Robertson, D. Houston, L. Malley, and T. J. Anderson Impaired brachial artery endothelial function is not predicted by elevated triglycerides J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2038 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Palomaki, K. Malminiemi, O. Malminiemi, and T. Solakivi Effects of Lovastatin Therapy on Susceptibility of LDL to Oxidation During {alpha}-Tocopherol Supplementation Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1541 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Toikka, P. Niemi, M. Ahotupa, H. Niinikoski, J. S. A. Viikari, T. Ronnemaa, J. J. Hartiala, and O. T. Raitakari Large-Artery Elastic Properties in Young Men : Relationships to Serum Lipoproteins and Oxidized Low-Density Lipoproteins Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Huggins, R. C. Pasternak, N. M. Alpert, A. J. Fischman, and H. Gewirtz Effects of Short-Term Treatment of Hyperlipidemia on Coronary Vasodilator Function and Myocardial Perfusion in Regions Having Substantial Impairment of Baseline Dilator Reverse Circulation, September 29, 1998; 98(13): 1291 - 1296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Cannon III Role of nitric oxide in cardiovascular disease: focus on the endothelium Clin. Chem., August 1, 1998; 44(8): 1809 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Plotnick, M. C. Corretti, and R. A. Vogel Effect of Antioxidant Vitamins on the Transient Impairment of Endothelium--Dependent Brachial Artery Vasoactivity Following a Single High-Fat Meal JAMA, November 26, 1997; 278(20): 1682 - 1686. [Abstract] [PDF]
|
|
|
|
|
|
U. Solzbach, B. Hornig, M. Jeserich, and H. Just Vitamin C Improves Endothelial Dysfunction of Epicardial Coronary Arteries in Hypertensive Patients Circulation, September 2, 1997; 96(5): 1513 - 1519. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. N. Diaz, B. Frei, J. A. Vita, and J. F. Keaney Antioxidants and Atherosclerotic Heart Disease N. Engl. J. Med., August 7, 1997; 337(6): 408 - 416. [Full Text] [PDF]
|
|
|
|
|
|
G. O'Driscoll, D. Green, and R. R. Taylor Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month Circulation, March 4, 1997; 95(5): 1126 - 1131. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Selwyn, S. Kinlay, P. Libby, and P. Ganz Atherogenic Lipids, Vascular Dysfunction, and Clinical Signs of Ischemic Heart Disease Circulation, January 7, 1997; 95(1): 5 - 7. [Full Text]
|
|
|
|
|
|
T. Matsunaga, D. W. Weihrauch, M. C. Moniz, J. Tessmer, D. C. Warltier, and W. M. Chilian Angiostatin Inhibits Coronary Angiogenesis During Impaired Production of Nitric Oxide Circulation, May 7, 2002; 105(18): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|